Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Capital Work in Progress ₹207 Cr₹493 Cr₹670 Cr₹372 Cr₹313 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹207 Cr based on Mar2024 Consolidated results.
Year Capital Work in Progress
Mar2024₹207 Cr
Mar2023₹493 Cr
Mar2022₹670 Cr
Mar2021₹372 Cr
Mar2020₹313 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2024 ₹207 Cr
-58.01
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr
80.26
Mar2021 ₹372 Cr
18.63
Mar2020 ₹313 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,144.2 Cr 0.7% -6.7% 10.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 1.3% 10.7% 49.3% Stock Analytics
CIPLA ₹121,326.0 Cr 2.2% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 2% -0.8% 15.7% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

0.7%

-6.7%

10.3%

SENSEX

1.9%

0.1%

10.9%


You may also like the below Video Courses